<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView%20%20&amp;noscript=1">

Unlocking the Future of Cancer Treatment: Your Path to Breakthrough Therapies

Date: November 6-8, 2024 (9-12 pm CET)

Locations: Zürich, Basel, and Lausanne

Join Crown Bioscience and our expert speakers Dr Enrico Pesenti – Executive Director for Scientific Engagement, Dr Julie Mayer – VP for Global Biomarker Platforms, and Dr Zhengzheng Bao – Head of Oncology, In Vitro, on a journey that will redefine the way oncology drug discovery and development is tackled.

Throughout the journey, our speakers will present cutting-edge approaches and technologies and their application in the development of novel cancer drugs as well as the relevance of biomarkers in preclinical and clinical development.

With our global capabilities we can support your drug development journey and evaluate novel targets, develop robust preclinical data, and accelerate clinical translation across various treatment modalities including ADC’s, T-cell engagers, Bi-specifics, and small molecules.

Don't just discover drugs. Create breakthroughs. Join us and be at the forefront of cancer treatment innovation. 
Together we can realize a world where every patient gets the right treatment, at the right time.

Register Now

Registration for the event is required. Attendance is free and food and drinks will be served, but spaces are limited. We encourage you to register early.


Speakers

Enrico Pesenti, PhD

Executive Director,
Scientific Engagement

Julie Mayer, PhD

Vice President
Global Biomarker Platform

Zhengzheng Bao, PhD

Head of Oncology
In Vitro

Locations

Zürich

Bio-Technopark Schlieren-Zürich
Wagistrasse 25
8952 Schlieren, Switzerland

Basel

Switzerland Innovation Park Basel Area
Hegenheimermattweg 167A
4123 Allschwil, Switzerland

 

Lausanne

Aquatis Hotel
Route de Berne 148
1010 Lausanne
Vaud, Switzerland

Share This

RESERVE YOUR SEAT

Your privacy is important to us.
We'll never share your information.